Sunday, July 19, 2026

Ohio or Bust and Imaging Results!

  We had a great visit with my parents and puppy, Oley. We had some fantastic thunderstorms and watched an even more fantastic FIFA World Cup 3rd place match. A great visit, all in all. 

 We’re now headed the 207 miles to visit Steve’s family. A few days there before heading back East to my Bone Marrow Aspirate procedure for my SURMOUNT clinical trial. 

 I mentioned MyChart in my last post and it still did not disappoint. I received timely results for all of my labs, CT Scans, and Nuclear Bone Scan (correction from PET Scan). I thought it was a PET Scan, but it was clarified it was strictly a Nuclear Bone Scan that uses 1/3 the nuclear isotope and is more specific to finding bone metastases. 

 Findings: NO METASTATIC DISEASE FOUND!!!!



 This gives me the green light to proceed with the SURMOUNT Clinical Trial and if all goes well, I will never have to do the ABBY Clinical Trial. I will have a Bone Marrow Aspirate every 6 months for 3.5 years as long as no disseminated tumor cells are found in my bone marrow. That’s best case scenario!

 Grateful for a sunny day with less wildfire smoke!



Friday, July 17, 2026

Labs, CT, and PET Scans at UPenn

 Today is a marathon day. After a great sleep at a hotel outside of the city, we’re headed into Philadelphia University City to the University of Pennsylvania Perelman Center for Advanced Medicine for all of my tests. 

 Before leaving, I couldn’t help but giggle at the continued, and unexpected, continuation of my shark theme. This was the shower set at our hotel:





 Now for the traffic report. We planned an early morning to get on the road and avoid as much traffic as possible. To put this in perspective, there are 738,700 people in ALL of Alaska. That’s just 1.3 person per square mile, just the way we like it. Now we’re on the road with the population of Philadelphia, 1.57 million, expand that to the surrounding areas, where we stayed, it expands to 6.33 million. Now add in the FIFA World Cup international visitors for the final game in just 2 days and we’re swimming in people. So far, my driver (my husband), has been doing a phenomenal job ducking and weaving through the lanes. I finally caved and got Waze (thanks Mom) which has been a tremendous help in finding the best route and knowing any upcoming hazards. 

 Today’s itinerary with a big shout out to MyChart by Epic, which makes it so easy to plan a day of appointments, even from 4,290 miles away:
0900 - Labs for ongoing clinical trial research
1000 - CT Scan of Chest, Abdomen, and Pelvis
1030 - Nuclear medication injection for PET Scan - see my past post for all the nuclear PET scan fun
1330 - PET Scan
~1430 - Drive 272 miles to Brookville to see my parents

 See you on the flip side!




Thursday, July 16, 2026

On the road again - Clinical Trial Trip #2

 As we were driving into Anchorage to catch our flight, we had the most beautiful rainbow appear. I will take that as a good omen. 


 We fly from Anchorage to Seattle to Philadelphia and arrive at 4:45 pm EST tomorrow. I will have a CT scan of my chest, abdomen, and pelvis and a PET scan to ensure I do not have any metastatic disease. 

If I do, I won’t be able to continue with the SURMOUNT study at this time. Of course, much more to come if that happens. 

If I do not, I will get my next bone marrow aspirate (BMA) on July 23rd at 9:45 am and then head back to Alaska at 4:30 pm the same day. 

The week between my imaging and BMA will allow us to visit my parents and my husband’s mother and then head back east in time for my BMA appointment. 

Here’s to safe travels and clear imaging! Final destination: Pennsylvania!





Monday, June 1, 2026

Correction: one year NED

 Just as I started this blog, I’m a realist but an optimist. I mistakenly stated that I was two years of no evidence of disease on my last post, when in fact, I’m only one. The clock for no evidence of disease begins on the date of your first clear scan after completing all necessary treatments. The other thing getting in my way is that I’m just not that great at math. Sorry for the confusion. One year down, nine to go.



Tuesday, May 19, 2026

Year 2 of No Evidence of Disease (NED)

  It is time to celebrate! Year 2 out of 10 without any evidence of any cancer coming back! 


  A quick review of BI-RADS is helpful before reading on. Due to my breast density, both a screening mammogram and breast MRI were warranted at my 2 year imaging. 

 My mammogram was found to be a BI-RADS category 2 which is benign with essentially 0% likelihood of cancer.

 My breast MRI was found to be a BI-RADS category 3 which is probably benign finding with short interval follow-up suggested with >0% but <2% likelihood of cancer. Repeat MRI suggested in 6 months. They're monitoring an area in the posterior aspect of the upper left breast (same side and close to the location as my original cancer) but does note it could be fat necrosis. When I told my sister about this, she said "I never thought of fat as being alive" which was a valid statement. Fat necrosis is a harmless, noncancerous condition where fatty tissue is damaged, dies, and forms a firm lump or oily cyst. Due to the size of the lumpectomy, my surgeon, who called me less than 24 hours from when my results were available, stated she's suspecting it is more of a fat necrosis situation and will monitor at the 6 month mark.



 In addition to my screening imaging, I also had a full spine MRI due to the areas found on my PET scan (revisit this information here). Long story short, all areas are stable and continue to appear as hemangiomas which are not an issue unless symptomatic, which they are not. I do have degenerative changes and one disc bulge in my neck, my midback, and my lower back. Hello 40s. 

 I think this is all the imaging I will have for now. In July, I continue on with my SURMOUNT trial and will have CTs of my chest, abdomen, and pelvis and a PET scan. If clear, I will have my 2nd bone marrow aspirate late July.
 
 With year 2 behind me, I'm focusing on transitioning back to future thinking, rather than just taking things one day at a time. It's harder than you may think.


Monday, April 20, 2026

Lost for Words Paper Co. - Now on Etsy!

  Throughout my experience with cancer, I have found myself making things that try to help those who otherwise need support while navigating cancer. I have chosen to open an Etsy shop to try to reach more people who may benefit from my creations. 

 Please visit lostforwordspaperco.etsy.com to see what I have available so far and comment below if you think there are certain parts of my blog or other information that you think I should make an informational sheet or worksheet to add.

 I plan to develop more in the world of cancer, Parkinson's Disease, caregiving, traumatic brain injury, and of course, patient experience.

 Feels weird to put myself out there in the world of creativity but there's no time like the present.



 



Sunday, April 12, 2026

When Ignorance is Bliss

  I've tried REAL hard to not spiral and worry about cancer recurrence. But even trying REAL hard doesn't mean it doesn't happen. 


Goal: Continue to live your life in the now and not worry about cancer recurrence.

Reality: You have a new ache, oop, it must be cancer. You have a spot on your arm, you rub it real hard and it doesn't come off, oop, it must be melanoma. Meanwhile, with a little soap, it comes right off. I usually laugh at myself once I rule out that this thing is not a recurrence or secondary cancer, but then it happens again.



 Most recently, this took place after my most recent labs taken at my oncology appointment. My oncologist says that my calcium level is a little elevated but it isn't anything to worry about right now. They said we'll check it again in 3 months. Me being me, I asked what a high calcium means. Almost nonchalant, they said "bone metastases". So I spin a little. Nothing to worry about? Easy for you to say. They then also mentioned hyperparathyroidism as a differential diagnosis and said that would be easy to treat with a referral to the same surgeon who did my breast cancer tumor removal since she specializes in thyroid as well. "Easy to treat" aka another surgery. Maybe I should define the word easy next time I see them.

 Now add on my review of the rest of my labs and I see that I have a slightly elevated total protein and MCH (Mean Corpuscular Hemoglobin (MCH) is a blood test measuring the average amount of hemoglobin in each red blood cell). I just took a continuing education course that stated that people don't "google" things because they don't believe their clinical team, they "google" because they're scared. Well...

Per Google AI:

The #1 potential cause of this lab triad is:

 "Primary Hyperparathyroidism: This is the most common cause of high blood calcium (hypercalcemia), accounting for ~90% of cases. It involves a benign tumor on one of the parathyroid glands, leading to high calcium, sometimes accompanied by altered protein and MCH levels." Primary treatment is surgery to remove the usually benign but occasionally, cancerous tumor. "Primary hyperparathyroidism occurs in approximately 2.88% to 7% of breast cancer patients, compared to roughly 0.1%–0.3% in the general population."

The #2 potential cause of this lab triad:

 "Multiple Myeloma: A type of blood cancer that often presents with a combination of high calcium, increased total protein (often due to high albumin or immunoglobulins), and can cause changes in red blood cells." I won't even go into the treatment for this. This would be considered a secondary cancer, with a "Standardized Incidence Ratio (SIR) of 1.5 indicates that the number of observed cases in a specific group is 50% higher than what would be expected based on the rates in a reference or "normal" population."




 Seems legit. But how do we score this? Well the Fear of Cancer Recurrence Inventory - Short Form, of course! Thanks, Canada!




 I won't be revealing my score so no one tries to hold me on a Title 47. Here is the scoring in case this pertains to you (of note, it can be for those in cancer treatment, cancer survivorship, or caregivers/family of persons with cancer):


"Low to moderate severity (0 to 15 on the FCRI-SF).
Because FCR is a common experience for cancer survivors, normalizing this experience for patients in a supportive and empathetic way is recommended. This could include discussion around the frequency with which survivors report FCR and common triggers of FCR (eg, hearing of someone being diagnosed with cancer, aches and pains, reminders of cancer experience in general). Uncertainty is inherent to FCR; therefore, providing information to cancer survivors and their caregivers on signs and symptoms of cancer recurrence, frequency of surveillance tests, and what to expect in cancer-related follow-up care, etc., can be helpful.

If maladaptive coping strategies are present, introducing more adaptive coping approaches such as engaging in enjoyed activities, meditation, yoga, physical activity, journaling about FCR, and talking to supportive friends and family about their fears can help decrease the severity of FCR among patients.

High and clinically significant severity (16 to 21 and ≥ 22 on the FCRI-SF, respectively).
For cancer survivors experiencing high (score of 16 to 21 on the FCRI-SF) and clinically significant (score of ≥ 22 on the FCRI-SF) levels of FCR, referral to allied health care professionals working in psychosocial cancer care might be appropriate. Psychotherapists can provide cognitive-behavioural approaches to address clinical FCR. Such interventions are empirically supported in group, online, and individual formats. Additional online resources on FCR (available at CFPlus) can be shared with cancer survivors who present with high FCR."

 Ok, back to real life. It continues to blow my mind how differently each person who encounters cancer reacts. I've observed that ignorance really can be bliss. 


For High FCR, CBT is known to help. See my previous posts for more information: 

Being present in the moment is a large part of CBT so I'll leave you with this:




Sunday, March 15, 2026

Exemestane and Letrozole

  Apologies for the significant delay since my last post on my ongoing treatment. My last post related to ongoing treatment outlined how tamoxifen was not as kind of a medicine as it had started out to be. Due to this, I was switched to one of three aromatase inhibitors - exemestane. Exemestane is different from Anastrozole or Letrozole (the other two) in that it is a steroidal aromatase inhibitor. This time, it only took about 1 month and it was determined that the side effects of severe anxiety and insomnia would not be side effects I can live with for the next 9 years. Once again, I was taken off the medication and had to wait 1 month to trial another. Enter Letrozole.

 I chose Letrozole because a family member had to use this in the past for 5 years and reported very minimal to no side effects. I figured it may be kind to me as well and so far, just over one month in, it's the lesser of all evils I've tried to date. I feel less fatigue and joint pain than when I was on Tamoxifen and no insomnia or anxiety like I felt with Exemestane. I'm experiencing minimal joint pain that I'm managing with naproxen. I'm also having some brain fog with word finding difficulties and short term forgetfulness, but I just do my best and move on. I'm hoping I've found the best one for me!




Type I and III Collagen and DTCs

  I received an email today talking about the benefits of type I and III collagen for skin and bone health and to help with joint pain and stiffness. That immediately sounded promising as I am at high risk of bone loss due to my postmenopausal state and aromatase inhibitor need to keep my estrogen levels as low as possible to prevent a recurrence of my cancer. I also love the idea of less joint pain and stiffness, which is also a side effect of my aromatase inhibitor, but also likely due to being in my 5th decade of life (surprised me too... apparently ages 0-9 is the 1st decade and you can go from there). So I read and then my brain starts cranking.

 I learn that the way collagen helps with bone health is due to its affect on bone marrow. Knowing that I am in a clinical trial that looks at my bone marrow, I do some research and find:



 From Google AI:

 Disseminated tumor cells (DTCs) interact with types I and III collagen in the extracellular matrix (ECM) to regulate survival, dormancy, and metastasis. Type III collagen often promotes dormancy in DTCs, while type I collagen induces stiffness that aids tumor progression, migration, and survival. 

Role of Collagen III (Dormancy and Stability)

  • Dormancy Marker: Type III collagen is crucial for establishing and sustaining the dormancy of disseminated tumor cells, preventing them from forming active metastases.
  • Signaling Mechanism: Binding of DDR1 on tumor cells to type III collagen triggers STAT1 signaling, maintaining a dormant state.
  • ECM Niche: High type III collagen, often in a "wavy," non-aligned structure, is associated with indolent (inactive) tumor niches. 

Role of Collagen I (Progression and Migration)

  • Stiffness & Migration: Type I collagen is the primary fibrillar collagen in the tumor stroma; its increased density and aligned, stiffened fibers promote cancer cell invasion and migration.
  • Survival Signal: DTCs interact with type I collagen through integrins, activating signaling pathways like FAK (focal adhesion kinase) to promote survival and resist anoikis. 
    • Anoikis is a specialized form of programmed cell death (apoptosis) triggered when anchorage-dependent cells, such as epithelial or endothelial cells, detach from the surrounding extracellular matrix (ECM) or neighbor cells. It acts as a critical mechanism to maintain tissue homeostasis and prevent misplaced cells from surviving and proliferating in inappropriate locations.

Implications for Metastasis

  • Switching States: A reduction in type III collagen, accompanied by increased type I collagen and fiber alignment, can drive dormant DTCs to transition into aggressive, proliferative metastatic cells.
  • Targeting Strategy: Targeting these ECM interactions, particularly maintaining high type III collagen or targeting type I-mediated signaling, is a potential strategy to keep disseminated tumor cells in a dormant state, say studies from PubMed Central (PMC) (.gov) and PubMed Central (PMC) (.gov).
 What may seem like a good suggestion for health could be life changing for someone with high risk of recurrence of cancer. While I do not have any DTCs present at this time (understanding the 40% chance of false negative for my first set of results), if I were to develop them, taking this supplement could lead to more aggressive, proliferative metastatic cells. Let's review that again...  aggressive, proliferative metastatic cells. No thank you! One could decide to take only Type III collagen which keeps DTCs in their dormant state, but the collagens available for use also include Type I. 

 All this to say that research, even of the most minor things, like collagen and turmeric, is essential to understand the role of common supplements in the ongoing treatments when living with cancer.


 Dissemination of CTCs and tumor dormancy. Breast cancer cells are shed in the proximal circulation where they are referred to as CTCs. Single CTCs or clusters of CTCs can disseminate and home to distant organs sites, where they are referred to as DTCs. DTCs are found predominantly in the bone marrow, but also lung, liver and the brain. While cellular dormancy typically refers to single DTCs or clusters of DTCs, dormancy of micrometastases also occurs, and these are characterized by a transient cell cycle arrest or an equilibrium of proliferation/apoptosis, respectively. DTCs can reawaken, eventually giving rise to macrometastatic lesions. 



Friday, February 27, 2026

SURMOUNT Clinical Trail Results from 1st Bone Marrow Aspirate

  I have received the results from my first bone marrow aspirate (BMA) and it shows that I have no disseminated tumor cells (DTCs) in my bone marrow at this time. This is great news! They said they received a good sample so that was encouraging as well. 



 At this time, due to no DTCs found in my first (out of a potential 7) bone marrow aspirates, I will proceed on the SURMOUNT Trial and will not transfer to the ABBY Trial. The next bone marrow aspirate will happen around July and will include some imaging to ensure there is no metastatic disease. I will be traveling back to Philadelphia to continue these trials.

 Of note, the first bone marrow aspirate can have a 40% false negative result so there is always a chance it is a false negative, but only serial bone marrow aspirates will determine that. By the fourth bone marrow aspirate, false negatives decrease to only 5%. In other words, it gets more accurate the more bone marrow aspirates that you get. Having no DTCs in your bone marrow also doesn't mean you have a 0% chance of having recurrence, but it is usually a good indicator.


 A bit surprising, I do still have tenderness where my bone marrow aspirate was taken. Naproxen has helped more than ibuprofen and my miracle cure, Arnicare Gel, helps as well. It does not appear to have any pockets of blood or fluid, so my guess is just the bone healing which can be delayed still due to being less than one year out of chemotherapy.

 This is great news and a great start to my 41st year of life!